Strattera and Folate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Folate (folic acid). Common drug interactions include upper respiratory tract infection among females and cognitive disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Folate. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Folate?

Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.



On Jul, 04, 2026

21 people who take Strattera and Folate together, and have interactions are studied.

Strattera and Folate drug interactions.

What are the common drug interactions of Strattera and Folate, by gender? *:

female:

  1. Upper respiratory tract infection
  2. Hearing disability
  3. Insomnia (sleeplessness)
  4. Middle ear effusion (fluid in middle ear)
  5. Seasonal allergy (allergic condition due to certain season)
  6. Anxiety
  7. Drug intolerance (drug sensitivity)
  8. Epistaxis (bleed from the nose)
  9. Hypoacusis (loss of hearing)
  10. Migraine (headache)

male:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Anger
  4. Anxiety
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Aspartate aminotransferase increased
  7. Balance disorder
  8. Blood alkaline phosphatase increased
  9. Blood prolactin increased
  10. Bone density increased

What are the common drug interactions of Strattera and Folate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hypersensitivity
  2. Somnolence (a state of near-sleep, a strong desire for sleep)

10-19:

  1. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  2. Photopsia (presence of perceived flashes of light)
  3. Plasma cell myeloma (cancer that begins in plasma cells)
  4. Pleural effusion (water on the lungs)
  5. Pneumonia
  6. Posterior capsule opacification
  7. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  8. Rib fracture
  9. Road traffic accident
  10. Second primary malignancy (after getting cure a cancer, a new cancer development)

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting

30-39:

  1. Agitation (state of anxiety or nervous excitement)
  2. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  3. Dystonia (abnormal muscle tone)
  4. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  5. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Presyncope
  3. Blood pressure increased
  4. Cardiac aneurysm (a condition that can occur after a myocardial infarction due to the inadequate resistance of the new scar tissue to the systolic pressure)
  5. Essential tremor
  6. Intention tremor (brain tremor)

50-59:

  1. Blood pressure decreased
  2. Dehydration (dryness resulting from the removal of water)
  3. Heart rate increased
  4. Hyperhidrosis (abnormally increased sweating)
  5. Skin turgor decreased (less elasticity of skin)
  6. Urine output decreased

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 38.10%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 38.10%
  3. Immunodeficiency Common Variable: 5 people, 23.81%
  4. Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Folate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Strattera and Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Folate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride and folic acid (the active ingredients of Strattera and Folate, respectively), and Strattera and Folate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: